The a2 Milk Company Limited (ASX:A2M)
Australia · Delayed Price · Currency is AUD | Market Cap | 5.29B -11.2% |
| Revenue (ttm) | 1.77B +21.1% |
| Net Income | 105.30M -29.9% |
| EPS | 0.14 -29.9% |
| Shares Out | n/a |
| PE Ratio | 50.27 |
| Forward PE | 28.48 |
| Dividend | 0.21 (2.86%) |
| Ex-Dividend Date | Mar 19, 2026 |
| Volume | 1,524,282 |
| Average Volume | 2,301,411 |
| Open | 7.14 |
| Previous Close | 7.08 |
| Day's Range | 7.08 - 7.31 |
| 52-Week Range | 6.96 - 9.97 |
| Beta | 0.42 |
| RSI | 27.59 |
| Earnings Date | Aug 15, 2026 |
About The a2 Milk Company
The a2 Milk Company Limited, together with its subsidiaries, sells A2-type protein type branded milk and related products in Australia, New Zealand, China, rest of Asia, and the United States. The company offers infant milk formula; other nutritional products and milk; manufactures and sells nutritional and ingredients products, as well as provides rent, royalty, and licensing services. It offers its products under the a2 Milk and a2 Platinum brands. The company was formerly known as A2 Corporation Limited and changed its name to The a2 Milk Co... [Read more]
Financial Performance
In fiscal year 2025, The a2 Milk Company's revenue was 1.90 billion, an increase of 13.50% compared to the previous year's 1.67 billion. Earnings were 202.89 million, an increase of 21.07%.
Financial numbers in NZD Financial StatementsNews
a2 Milk Company (ACOPY) Lowers Revenue and Profit Forecast Amid Supply Chain Issues
a2 Milk Company (ACOPY) Lowers Revenue and Profit Forecast Amid Supply Chain Issues
A2 Milk Cuts Guidance As Supply Disruptions Drive 15% Share Drop
A2 Milk Cuts Guidance As Supply Disruptions Drive 15% Share Drop
Profit warning as a2 Milk struggles to ship baby formula to China
The ASX-listed company said there could be temporary shortfalls in products over the next two months, sending shares sliding by more than 16 per cent.
ASX 200 news from Monday 13th April 2026:ASX ends down on Trump’s Hormuz threat, sending oil soaring; A2 Milk hit by downgrade
Shares down as oil soars on Hormuz blockade threat; ANZ warns of long-term impact from war; Insignia investors back takeover; A2 Milk cuts outlook; EML hits 13-year low. Follow live.
The a2 Milk Company Earnings Call Transcript: H1 2026
Delivered strong double-digit revenue and EBITDA growth, driven by core products and innovation across all regions. Upgraded FY 2026 guidance to mid double-digit revenue growth and tightened EBITDA margin range, with continued market share gains in China and new product launches supporting future growth.
The a2 Milk Company Transcript: AGM 2025
Shareholders heard of strong FY 2025 results, with 13.5% revenue growth and major supply chain transformation, including a new manufacturing facility and expanded China market access. Dividend payouts increased, new directors were elected, and strategic initiatives in innovation, sustainability, and emerging markets were highlighted.
The a2 Milk Company Earnings Call Transcript: H2 2025
Record FY 2025 results with NZD 1.9B sales, 13.5% revenue growth, and strong China/Asia performance. Major supply chain transformation announced, including Yashili NZ acquisition and MVM divestment, with high single-digit revenue growth and 15%-16% EBITDA margin targeted for FY 2026.
The a2 Milk Company Earnings Call Transcript: H1 2025
Delivered 10% revenue growth and upgraded FY2025 guidance, driven by strong China and English Label IMF performance, new product launches, and improved supply chain. Declared first-ever dividend and maintained robust cash position.
The a2 Milk Company Transcript: AGM 2024
Shareholders were updated on strong FY24 financial results, new board appointments, and the introduction of a dividend policy. Strategic priorities include supply chain transformation, product innovation, and market expansion, with ongoing focus on China and new regions. Key risks discussed included China market exposure and competitive pressures.
The a2 Milk Company Earnings Call Transcript: H2 2024
Revenue, EBITDA, and EPS all grew in FY 2024, driven by strong China performance and record market share gains, despite a declining IMF market. FY 2025 guidance anticipates mid-single digit revenue growth, with supply constraints in the first half and margins broadly similar to FY 2024.